Open access · US-GOV
via ClinicalTrials.gov Clinical trial
Sex-Specific Effects of Endocrine Disruption on Aging and Alzheimer's Disease
Authors not listed
Mayo Clinic · 2019
Abstract
The researchers are trying to determine whether ovarian hormones are associated with aging processes and with the risk of developing Alzheimer's disease in women.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- ClinicalTrials.gov
- Canonical
- link ↗
- Fetched
- 2026-05-31 MST
Cite this
APA
Anonymous. (2019). Sex-Specific Effects of Endocrine Disruption on Aging and Alzheimer's Disease. <em>Mayo Clinic</em>. https://clinicaltrials.gov/study/NCT03821857
Vancouver
Anonymous. Sex-Specific Effects of Endocrine Disruption on Aging and Alzheimer's Disease. Mayo Clinic. 2019.
BibTeX
@misc{anon2019SexSpe,
title = {Sex-Specific Effects of Endocrine Disruption on Aging and Alzheimer's Disease},
author = {Anonymous},
journal = {Mayo Clinic},
year = {2019},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Ageing Research Reviews 2016
Preprint · OA
Cystatin C in aging and in Alzheimer’s disease
Springer eBooks 2015
Citation only
The Role of Aging in Alzheimer’s Disease
The Lancet 2021
Preprint · OA
Alzheimer's disease
Handbook of clinical neurology 2019
Citation only
Alzheimer's disease
Nature Reviews Neurology 2024
Preprint · OA
Is Alzheimer disease a disease?
Progress in molecular biology and translational science 2017
Preprint · OA